NCT07544238

Brief Summary

The participating researchers register all adult patients (who have given informed written consent) scheduled for elective repair of an abdominal wall hernia (NOT inguinal hernias) via minimally invasive operation technique (i.e.: laparoscopy or robotic repair) and perform a follow up of 5 years to analyze clinical outcome parameters. These parameters include recurrence of the hernia, intra- and postoperative complications, quality of live, esthetic outcome and pain. The patients will be reviewed in person by the participating researchers at 2-3 moths, 1 year, 3 years and 5 years after surgery. A computed tomography will be performed at 1 year after surgery and in case of suspicion of complications, for example hernia recurrence. The treatment and follow-up of the participating patients does not differ from the standard treatment protocol (and the not participating patients).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
121mo left

Started Apr 2026

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Apr 2026Apr 2036

Study Start

First participant enrolled

April 14, 2026

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 15, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 22, 2026

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 14, 2036

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 14, 2036

Last Updated

April 27, 2026

Status Verified

April 1, 2026

Enrollment Period

10 years

First QC Date

April 15, 2026

Last Update Submit

April 22, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Hernia recurrence rate

    Percentage of all the patients intervened who present a radiologically (via CAT Scan or MRI in case of contraindication for CAT Scan) confirmed hernia recurrence. In case of suspicion (physical exam and/or symptoms reported by the patient) a CAT Scan will be performed to confirm or discard the diagnosis, at any time of the follow-up

    5 years (the time to recurrence will be defined by the moment of radiological confirmation)

Secondary Outcomes (9)

  • Postoperative complications Clavien Dindo

    90 days after surgery

  • Surgical Site Occurrence (SSO)

    5 years

  • Perioperative bleeding

    30 days

  • Mortality

    5 years

  • Hernia associated quality of life

    5 years

  • +4 more secondary outcomes

Study Arms (1)

All adult patients with indication of elective minimally invasive abdominal wall hernia surgery

The patients will be intervened by laparoscopic or robotically assisted hernioplastia of midline or lumbar hernias, either primary or secondary in nature. Inguinal hernias will only be included if they exist apart from the primarily targeted midline or lumbar abdominal wall hernia

Procedure: Minimally invasive hernioplastia

Interventions

laparoscopic or robotically assisted hernioplastia

All adult patients with indication of elective minimally invasive abdominal wall hernia surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All adults referred to our department presenting an abdominal wall hernia with surgical indication

You may qualify if:

  • Indication for elective minimally invasive ventral hernia repair due to criteria of the participating surgeons

You may not qualify if:

  • Patient rejects participation or giving written informed consent
  • Positive pregnancy test (Beta HCG in serum)
  • Patients who do not meet criteria for minimally invasive surgery due to the criteria of the including surgeon or anesthesiologist (Loss of domain, giant abdominal wall herniae, very small (W1) isolated midline hernia, severe pulmonary or cardiac pathologies)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario Fundacion Jiménez Díaz

Madrid, Madrid, 28040, Spain

RECRUITING

Central Study Contacts

Marius Kaeser, Doctors Degree

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Surgical Staff, Surgeon in the department of General Surgery of the Hospital Universitario Fundación Jiménez Díaz

Study Record Dates

First Submitted

April 15, 2026

First Posted

April 22, 2026

Study Start

April 14, 2026

Primary Completion (Estimated)

April 14, 2036

Study Completion (Estimated)

April 14, 2036

Last Updated

April 27, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

All the raw data registered and relevant for the described primary and secondary outcomes, but NOT the personal details necessary to identify the person (birth date, name, medical record number). In essence: only the pseudonymized data is provided.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
From the beginning until the end of the follow-up (from 14/04/2026 until the 14/04/2036)
Access Criteria
Only the participating investigators of our hospital

Locations